Yuyu Pharma유유제약
000220 · KOSPI · ₩000220 · 유유제약
₩3,670▲ ₩30 (0.82%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 38.8% | 38.3% | 38.8% | 35.6% | 38.4% | 39.2% |
| Operating margin | 9.1% | 7.8% | 8.8% | 0.3% | −0.4% | 1.0% |
| Net margin | 8.7% | 5.8% | 6.5% | −5.2% | −4.3% | −1.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +2.5% | +5.8% | −3.0% | −1.2% | +20.1% | — |
| Operating income growth | +19.4% | −5.8% | +3,108.8% | +161.6% | −149.3% | — |
| Net income growth | +53.3% | −6.5% | +221.4% | −19.9% | −170.5% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 9.5% | 6.4% | 7.3% | −6.3% | −5.0% | −1.8% |
| Return on assets | 5.8% | 4.4% | 5.1% | −2.8% | −2.3% | −0.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 42.2% | 47.4% | 53.8% | 64.7% | 58.2% | 50.0% |
| Net debt to equity | −10.9% | — | — | — | — | — |
| Current ratio | 189.2% | 164.4% | 158.1% | 203.3% | 149.8% | 329.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Yuyu Pharma / 유유제약 / 000220 / KRX:000220
Source: KRX statistical information